Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)

CUSIP: 738920107

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
138,530,928
Total 13F shares
3,123,043
Share change
+1,078,739
Total reported value
$645,607
Price per share
$0.21
Number of holders
25
Value change
+$222,104
Number of buys
15
Number of sells
7

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 738920107?
CUSIP 738920107 identifies ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Lance Friedman
13D/G
4.5%
2,207,886
$1,037,706 -$782,315 06 May 2025
Procyon Advisors, LLC
13F
Company
0.47%
648,411
$174,423 30 Jun 2025
13F
Crewe Advisors LLC
13F
Company
0.45%
626,854
$168,624 30 Jun 2025
13F
Harraden Circle Investments, LLC
13D/G
0.31%
150,000
$70,500 $0 31 Mar 2025
Optivise Advisory Services LLC
13F
Company
0.17%
235,106
$63,244 30 Jun 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
class O/S missing
1,050,000
$46,935 30 Jun 2025
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
983,603
$44,213 30 Jun 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.11%
152,552
$41,036 30 Jun 2025
13F
LINDEN ADVISORS LP
13F
Company
class O/S missing
899,999
$40,500 30 Jun 2025
13F
VR Advisory Services Ltd
13F
Company
mixed-class rows
197,083
mixed-class rows
$30,650 30 Jun 2025
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
class O/S missing
681,516
$30,634 30 Jun 2025
13F
TORONTO DOMINION BANK
13F
Company
class O/S missing
516,845
$23,103 30 Jun 2025
13F
Sculptor Capital LP
13F
Company
class O/S missing
500,000
$22,475 30 Jun 2025
13F
PERISCOPE CAPITAL INC.
13F
Company
mixed-class rows
199,924
mixed-class rows
$20,593 30 Jun 2025
13F
Three Seasons Wealth, LLC
13F
Company
0.05%
75,000
$20,175 30 Jun 2025
13F
Verition Fund Management LLC
13F
Company
class O/S missing
432,757
$19,344 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
class O/S missing
350,000
$15,645 30 Jun 2025
13F
CLEAR STREET LLC
13F
Company
class O/S missing
331,064
$14,799 30 Jun 2025
13F
Taconic Capital Advisors LP
13F
Company
class O/S missing
300,000
$13,410 30 Jun 2025
13F
VALLEY WEALTH MANAGERS, INC.
13F
Company
0.03%
40,000
$10,760 30 Jun 2025
13F
Platform Technology Partners
13F
Company
0.03%
37,611
$10,117 30 Jun 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
199,999
$8,940 30 Jun 2025
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
195,944
$8,758 30 Jun 2025
13F
Context Capital Management, LLC
13F
Company
class O/S missing
175,000
$7,823 30 Jun 2025
13F
Donald G. Fell
3/4/5
Director
0.01%
20,000
$7,800 $0 04 Jun 2025
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
25,000
$7,000 30 Jun 2025
13F
NOMURA HOLDINGS INC
13F
Company
class O/S missing
150,000
$6,750 30 Jun 2025
13F
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
138,536
$6,227 30 Jun 2025
13F
Athos Capital Ltd
13F
Company
class O/S missing
21,383
$6,000 30 Jun 2025
13F
LMR Partners LLP
13F
Company
class O/S missing
125,000
$5,588 30 Jun 2025
13F
WHITEBOX ADVISORS LLC
13F
Company
class O/S missing
118,750
$5,308 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.01%
18,701
$5,031 30 Jun 2025
13F
Clear Street Derivatives LLC
13F
Company
class O/S missing
106,000
$4,738 30 Jun 2025
13F
Scientech Research LLC
13F
Company
0.01%
16,514
$4,442 30 Jun 2025
13F
Limestone Investment Advisors LP
13F
Company
class O/S missing
75,000
$3,353 30 Jun 2025
13F
Allred Capital Management, LLC
13F
Company
0.01%
11,185
$3,009 30 Jun 2025
13F
Blue Owl Capital Holdings LP
13F
Company
class O/S missing
50,000
$2,235 30 Jun 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.01%
7,108
$1,912 30 Jun 2025
13F
OMERS ADMINISTRATION Corp
13F
Company
class O/S missing
25,000
$1,118 30 Jun 2025
13F
PICTON MAHONEY ASSET MANAGEMENT
13F
Company
class O/S missing
50,000
$1,000 30 Jun 2025
13F
FLOW TRADERS U.S. LLC
13F
Company
class O/S missing
14,491
$1,000 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0%
2,500
$673 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
271
$73 30 Jun 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
mixed-class rows
150
mixed-class rows
$28 30 Jun 2025
13F
Surendra K. Ajjarapu
3/4/5
Chief Executive Officer, Director, 10%+ Owner
class O/S missing
4,317,500
18 Aug 2023
PowerUp Sponsor LLC
3/4/5
10%+ Owner
class O/S missing
2,870,000
18 Aug 2023

Institutional Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q3 2025

As of 30 Sep 2025, Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,123,043 shares. The largest 10 holders included Crewe Advisors LLC, Procyon Advisors, LLC, VANGUARD GROUP INC, Optivise Advisory Services LLC, GEODE CAPITAL MANAGEMENT, LLC, Antara Capital LP, VR Advisory Services Ltd, Resolute Advisors LLC, Three Seasons Wealth, LLC, and P SCHOENFELD ASSET MANAGEMENT LP. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
16
Q3 2025 holders
25
Holder diff
9
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.